EU/CORE Risk Management Plans (RMP)

Compulsory for all European drug submissions since 2012, Risk Management Plans (RMPs) must additionally comprise a Summary of the RMP (Part VI), which aims to elucidate the hazards associated with the drug in a manner comprehensible to patients.

We can assist you in determining your requirements and preparing the necessary documents through consultation. D L Global Services is equipped to handle the arduous pharmacovigilance reporting that is necessary.

Our proficiency in conveying safety information and drug advantages in language that is comprehensible, easily obtainable, and patient-oriented grants you the chance to alleviate an additional concern.